Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The Neonatal Gastrointestinal Tract: Developmental Anatomy, Physiology, and Clinical Implications Josef Neu and Nan Li NeoReviews 2003;4;7 DOI: 10.1542/neo.4-1-e7 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://neoreviews.aappublications.org/cgi/content/full/neoreviews;4/1/e7 NeoReviews is the official journal of the American Academy of Pediatrics. A monthly publication, it has been published continuously since 2000. NeoReviews is owned, published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2003 by the American Academy of Pediatrics. All rights reserved. Online ISSN: 1526-9906. Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 Article gastroenterology The Neonatal Gastrointestinal Tract: Developmental Anatomy, Physiology, and Clinical Implications Josef Neu, MD,* Nan Li, MD, MS* Objectives After completing this article, readers should be able to: 1. Describe key elements of the developmental anatomy of the gastrointestinal tract and how it relates to nutrition in low-birthweight infants. 2. Characterize key elements of the developmental physiology of the gastrointestinal tract, including gastroesophageal sphincter function, gastric emptying, and intestinal motility, along with clinical implications. 3. Describe key elements of the development of digestive absorptive functions and how these relate to nutrition of the preterm and term neonate. 4. Explain minimal enteral and parenteral nutrition for very low-birthweight infants. 5. Describe potential areas for future investigation. Introduction The past 20 years has witnessed a surge of interest in gastrointestinal (GI) development and neonatal nutrition. Application of basic knowledge of intestinal development and appropriate nutrition for critically ill and preterm infants can be used to ameliorate short-term morbidity in infants who would not have survived prior to 20 years ago. Long-term morbidity also may be affected by improved nutrition because these infants are undergoing critical periods of development during which poor nutrition may have life-long consequences. The focus of previous research has been various aspects of morphology, basic biochemistry and physiology of the developing GI tract, and how this knowledge can be applied to nutrition of the neonate. More recently, the advent of molecular biology and other technological advances has initiated a new era of research into these areas, which are being termed “omics” and include genomics, proteomics, methylomics, and metabolomics (see Young et al in Suggested Reading). These emerging fields offer exciting opportunities to understand better the various aspects of development that will be subsequently applied to diagnosis, prevention, and treatment of diseases. Anatomic Development The intestine undergoes tremendous growth during fetal life. It elongates 1,000-fold from 5 to 40 weeks’ gestation, with the length doubling in the last 15 weeks of gestation to a mean of 275 cm at birth. In the small intestine, villi already are formed at 16 weeks’ gestation. Villi also are present in the large intestine, but these partially regress at approximately 29 weeks’ gestation. Microvilli begin to cover the apical surface of the small intestinal epithelium so that by adulthood, the intestinal surface provides the largest interface between the outside environment and the internal milieu (approximately 2,000,000 cm2, which is nearly the size of a tennis court). After intestinal epithelial cells undergo mitotic cell division in the crypt, they migrate up the villus, where they undergo differentiation and become actively absorbing cells, which are sloughed from the villus tip into the intestinal lumen. Although not adequately studied in humans, there is reason to believe that the migration time is similar to that found in rodents, where the turnover time in the adult is approximately 48 hours and in the infant is about 96 hours (Fig. 1). Numerous cell types exist in the small intestine (Fig. 2). These include the intestinal *Department of Pediatrics, University of Florida, College of Medicine, Gainesville, FL. This work was supported in part by NIH grant R01HD3894. NeoReviews Vol.4 No.1 January 2003 e7 Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 gastroenterology anatomy & physiology absorptive epithelium, Paneth cells (involved in secretion of defensins and other peptides involved in innate immunity), goblet cells (involved in the secretion of the mucus overlying the intestine), and other cell types associated with the intestinal neuroendocrine system and immune system. Physiologic Development Amniotic Fluid Swallowing Many physiologic processes develop during fetal life. One that is considered particularly important is fetal swallowing. The fetus swallows about 450 mL/d of amniotic fluid in the third trimester. This fluid contains nutrients and growth factors, but its availability is interrupted suddenly at the time of preterm birth. There is speculation that this sudden interruption of large fluid fluxes from fetal life to extrauterine life might have detrimental consequences (Fig. 3). Gastroesophageal Sphincter Tone Gastroesophageal (GE) sphincter tone also undergoes remarkable changes during development. The lower esophageal pressure is approximately 4 cm H2O and 28 cm H2O in preterm and term infants, respectively (Fig. 4). This is related to the high incidence of GE reflux (GER) in preterm infants. Of note, GER has been implicated as one of the causes of apnea and bradycardia in very low-birthweight (VLBW) infants. This has led to the frequent use of prokinetic agents, although welldesigned, controlled studies supporting their safety and efficacy are lacking. More recent data suggest that most cases of apnea and bradycardia in VLBW infants are not causally related to GER. Intestinal Motility Delayed gastric emptying also is related to GER because gastric emptying is slower in preterm than in term infants. In the adult, the rate of gastric emptying is controlled by feedback from the small intestine. Stimulation of duodenal receptors by acid, fat, carbohydrate, tryptophan, or increasing osmolality decreases the rate of gastric emptying. Studies of the effects of various formula components on gastric emptying have yielded conflicting results. Incremental increases of caloric density from 0.2 to 0.66 kcal/mL decreased the rate of gastric emptying among infants of 32 to 39 weeks’ gestation, but there were no differences with increments of 0.6 to 0.8 kcal/mL formula. Despite the reduced emptying rate at higher caloric density, the quantity of calories delivered into the duodenum from the stomach increased with concentrated formula. Changes in osmolality from e8 NeoReviews Vol.4 No.1 January 2003 279 to 448 mOsm/kg do not alter significantly the rates of gastric emptying of isocaloric formulas. No information on the ability of duodenal feedback to control the rate of gastric emptying in the VLBW infant between 25 and 32 weeks’ gestation is available. Inadequate control of emptying could overwhelm the intestinal tract, leading to malabsorption and feeding intolerance. Therapeutic agents that increase gastric emptying rates in children and adults also appear to be effective in preterm infants. Metoclopramide and cisapride increase the gastric emptying rate in preterm and term infants. Nasojejunal feeding may provide only limited improvement in feeding tolerance because intestinal motility beyond the gastric outlet is also immature. The small bowel motility patterns are poorly developed before 28 weeks’ gestation. The small intestine shows disorganized motility patterns between 27 and 30 weeks’ gestation, which progress to a more mature pattern in which migrating myoelectric complexes are present at 33 to 34 weeks’ gestation. Gastroanal transit ranges from 8 to 96 hours in preterm infants compared with 4 to 12 hours in adults. In preterm infants, the motilin receptor is not present until 32 weeks’ gestation, and the cyclic release of motilin is not present. This suggests that the use of erythromicin would not be effective prior to 32 weeks’ gestation, although more recent studies suggest improved feeding tolerance with erythromicin. Protein Digestion Knowledge of digestive-absorptive processes has increased significantly in the past 2 decades. Gastric acid secretion is limited in VLBW infants. In the first 24 to 48 hours after birth, intragastric pH remains at about 5.5 to 7.0 and is relatively resistant to pentagastrin. However, both basal and pentagastrin-stimulated acid secretion doubles from the first to fourth week of postnatal life in preterm infants. This process should be kept in mind when considering the use of histmine2 (H2) blockers, which are widely prescribed in many neonatal intensive care units. Gastric acid can serve as a barrier to microorganisms. When gastric acid secretion is decreased by the use of inhibitors, this can lead to a higher load of bacteria in the more distal regions of the intestine. Several studies suggest that critically ill patients treated with H2 blockers have a higher incidence of nosocomial sepsis. Some of the enzymes involved in intraluminal digestion of proteins are also relatively limited in preterms. Pepsin secretion usually is fully developed by 3 to 8 months of postnatal age, and levels are much lower in Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 gastroenterology anatomy & physiology preterm than in term newborns (639 U/Kg versus 3,352 U/Kg in adults). This could be a limiting factor for the digestion of certain types of protein in preterm infants. The protease cascade in the small intestine is catalyzed by food-stimulated secretion of enterokinase from the upper small intestinal epithelium (Fig. 5). This enzyme catalyzes the activation of trypsinogen to trypsin that, in turn, activates several other inactive zymogens into proteases, which are active in the intestinal lumen. However, even though enterokinase is detectable at 24 weeks’ gestation, its concentration is relatively low and reaches only 25% of adult activity at term. This can be limiting to protein digestion and may be responsible for an increased capability of larger antigens or microorganisms to pass into the intestine without breakdown by luminal enzymes. Lipid Digestion and Absorption Lipid requirements are limited to the 18-carbon essential fatty acids (linoleic or linolenic acid). Lipid makes up about 50% of the nonprotein energy content of human milk and formulas, both of which contain these fatty acids. However, both term and preterm infants have pancreatic insufficiency compared with older children and adults. The digestion of lipid can be split into several phases. The luminal phase involves de-esterification of triglycerides to 3-monoglyerides and free fatty acids and bile acid-mediated micellar solubilization. In the process of fat digestion, several lipases hydrolyze fatty acids from glycerol. Figure 6 shows some of these, which include the lipase found in human milk (bile salt-stimulated lipase) and lingual, gastric, pancreatic, and epithelial lipases. Bile acid-stimulated lipase is present in milk and becomes active in the small intestine lumen in the presence of bile acids. Lingual lipase is secreted by glands at the base of the tongue and is involved in gastric lipid hydrolysis. Lipases produced in the stomach, secreted from the pancreas, and present in the mucosa also are involved in lipid hydrolysis. Bile acids are critical to efficient fat digestion and absorption. These processes are limited in VLBW infants because the duodenal concentration of bile acids is low due to lower synthesis and ileal reabsorption (Fig. 7). Lower micellar solubilization leads to inefficient cellmucosal interaction and subsequently lower absorption of the molecules of the mucosal-cell surface interface (Fig. 8). Long-chain fatty acids but not medium-chain fatty acids depend on bile acids for solubilization and, thus, are the most susceptible to inefficient absorption. The permeation of fatty acids and 2-monoglycerides from the lumen into the cell, intracellular reesterification, chylomicron formation, and transport to the chylomicrons from the cell into the circulation are the primary absorptive events. After lumenal digestion, fatty acids and monoglycerides approximate the absorptive surface and enter the intracellular milieu by processes that are not yet well understood. After entry into the cell, medium-chain triglycerides undergo a relatively simple process of assimilation in which they do not undergo re-esterification and chylomicron formation, as the longchain lipids do. Medium-chain triglycerides are taken directly into the portal venous system; chylomicrons formed from long-chain fats enter the lymphatics. In conditions that involve obstruction of the lymphatics, feeding formulas containing primarily medium-chain triglycerides rather than long-chain triglycerides are recommended. There is considerable interest in the capability of neonates to convert the essential fatty acids into longerchain fatty acids with 20 or more carbons. These longchain polyunsaturated fatty acids (LCPUCAs) are critical in the formation of eicosanoids and structural components of the central nervous system. They are found in relatively high concentrations in human milk but are not found in total parenteral nutrition or most neonatal formulas. Whether the addition of LCPUCAs to formulas results in improved neurodevelopment is the subject of current intense investigation. Most essential fatty acids provided to neonates are derived from the omega-6 family (linoleic acid). This is because much of the lipid derived from formulas or intravenous lipid solutions is from vegetable oil, which is rich in the omega-6 but not the omega 3 fraction. The implications of this will be discussed in the article on immunonutrients in this issue of NeoReviews. Carbohydrate Digestion and Absorption Carbohydrates ingested by neonates are either natural lactose (the primary carbohydrate in most human and mammalian milks) or glucose polymers, sucrose, or hydrolyzed starches. Mechanisms for carbohydrate absorption mature in a defined sequence during human fetal development. The intestinal enzymes lactase, sucrase, maltase, isomaltase, and glucoamylase are at mature levels in the term fetus. Pancreatic amylase activity is low in both term and preterm neonates and appears to require several months to reach mature levels. In the preterm infant, sucrase, maltase, and isomaltase are usually fully active, but lactase activity, which increases markedly from 24 to 40 weeks’ gestation, may be low, depending on NeoReviews Vol.4 No.1 January 2003 e9 Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 gastroenterology anatomy & physiology fetal age. Despite these developmental patterns, clinical lactose intolerance is uncommon. Postnatal adaptive responses to ingested carbohydrates lead to competent carbohydrate absorption. Inadequately absorbed carbohydrates are salvaged by colonic flora through fermentation to hydrogen gas and short-chain fatty acids, the latter of which the colon readily absorbs. One study was designed to ascertain whether the timing of feeding initiation affected the development of intestinal lactase activity and whether there are clinical ramifications of lower lactase activity. Early feeding increased intestinal lactase activity in preterm infants. Lactase activity is a marker of intestinal maturity and may influence clinical outcomes. Whether the effects of milk on lactase activity were due to the greater concentration of lactose in human milk compared with that in formula has not yet been determined. The presence of a high lactose concentration in human milk should not be a contraindication for its use in the VLBW infant. Feedings for VLBW infants rarely are initiated at levels intended to meet the infants’ entire nutritional requirements and usually are advanced slowly. The rationale for using a lactose-free formula instead of human milk or even a commercial lactosecontaining formula is weak and theoretically may be harmful. Slow initiation of enteral feedings is unlikely to exceed the lactose hydrolytic and salvage capability of the small and large intestines. This is especially unlikely when the quantity fed is less than 50% of the caloric requirement provided via the GI tract (unless the infant has a bowel that has been radically shortened by surgery). Human milk also contains several lactose-derived oligosaccharides and other glycoconjugates that may play important roles in the infant’s host defense. Studies examining the crypt-to-villus gradient of intestinal carbohydrase activities demonstrate that most lactase activity is found at the mid- to upper villus; sucrase, maltase, and glucoamylase are concentrated at the mid-villus region (Fig. 9). This is likely to be pertinent to intestinal injury and villus damage. Lactase usually is the first enzyme to be lost and the last to be regenerated fully. Pancreatic amylase, which cleaves internal alpha-1 to -4 glucose bonds to maltose, maltoriose, limit dextrin, and glucose, is a major enzyme that hydrolyzes starches (Fig. 10). Because pancreatic secretion is poorly developed in the first several months following birth, this mode of starch hydrolysis could serve as a limiting factor that leaves substantial undigested starch in the intestine. Some data suggest that glucose polymers (18 to 29 glucose units) can be hydrolyzed by salivary amylases, e10 NeoReviews Vol.4 No.1 January 2003 but this digestion still falls substantially short of that accomplished by the usual concentrations of pancreatic amylase. Many infant formulas, including those formulated for preterm infants, contain corn syrup solids or tapioca, which are partially hydrolyzed starches. The more extensively the starch is hydrolyzed, the less reliance is placed on an immature digestive capability, but the greater the osmolality. Whether there is any advantage of these hydrolyzed starch formulas over those containing disaccharides or lactose has not been established. Minimal Enteral Nutrition Considerable emphasis has been placed on nutrition of the low-birthweight infant after the period of critical illness. Until recently, few systematic studies evaluated the best method of nourishing the infant during the period of critical illness, when he or she is receiving mechanical ventilation and is likely to be the most catabolic in the first 2 to 3 weeks after birth. This is a period of extremely high vulnerability and high nutrient requirement. A lack of essential nutrients during this time may result in life-long consequences. Because of individual patient characteristics, one feeding protocol or guideline cannot be used for all infants. Data from the available studies suggest that minimal enteral feedings should be instituted within the first days after birth. Because of the fear of necrotizing enterocolitis, feeding intolerance, and metabolic problems resulting from inappropriate intakes of parenteral nutrients, neonatologists commonly withhold both enteral and intravenous amino acids and lipids. Commonly used excuses to withhold enteral feedings include low Apgar scores, umbilical catheter use, apnea and bradycardia, mechanical ventilation, continuous positive airway pressure, and administration of vasoactive drugs and indomethacin. None of these has been demonstrated to preclude enteral feedings in the low-birthweight infant. At least 10 studies of minimal enteral nutrition have been published, all of which document safety and efficacy (Fig. 11). Minimal enteral nutrition is defined as an enteral intake that is less than the full nutrient requirements of the neonate, but that has been found to prime the GI tract for subsequent feedings (usually ⬍20 mL/kg of human milk or formula). Infants given early minimal enteral nutrition have faster maturation of motor patterns and release of GI hormones than infants given no enteral feedings. These infants also have less feeding intolerance, establish oral feedings sooner, and do not differ from nonfed infants in their incidence of necrotizing enterocolitis. Motor re- Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 gastroenterology anatomy & physiology sponses appear to be less intense with the more diluted formulas. The amount of volume does not appear to benefit maturing motor function. Motor responses are equally intense whether feedings are instilled intragastrically or transpylorically. They are similar whether feedings are provided chilled, at room temperature, or warmed to body temperature. When infants are fed a slow infusion over 120 minutes, they display an intense fed response that is accompanied by brisk gastric emptying. However, when the same volume is fed over 15 minutes, duodenal motor responses are far less intense and are accompanied by delayed gastric emptying. Because two thirds of preterm infants display an immature duodenal fed pattern that is accompanied by delayed gastric emptying, many preterm infants may not be as physiologically prepared to process bolus feedings as well as slow infusion feedings from the viewpoint of motor activity. Parenteral Nutrition It has been common practice to withhold both lipids and amino acids from parenteral nutrition for several days, then increase them slowly so that intakes approximating in utero intake are reached by 7 to 10 days. This can lead to a significant decrement in protein and lipid nutrition. Studies now suggest that it is safe to initiate amino acids at 3.0 g/kg per day as early as day 1 after birth. Lipids also can be started within the first days after birth. There is no evidence of harm at lipid infusion rates of less than 0.2 g/kg per hour. The Future Current developments, such as the Human Genome Project, proteomics, and other technologies, will increase the understanding of neonatal nutrition and GI development, thereby allowing diagnosis and prevention of some illnesses. A few of the biggest challenges for the future include understanding: ● ● ● Mucosa-microbial interactions (cross-talk between microbes, epithelium, submucosa) Barrier function (intercellular junctions) Activation and deactivation of genes and interaction between genomic and extragenomic metabolic pathways Figure 12 describes terms that will aid in understanding these future directions. One example of an area that will receive intense scrutiny involves early metabolic “programming” and subsequent disease. Several studies suggest that nutrient re- striction in utero may have major implications for postnatal development long-term. Very little is known about the effects of nutrient restriction in the neonatal intensive care unit during very vulnerable periods of growth and development that might result in programming that can have long-term effects. An improved understanding of GI development and neonatal biochemical nutrition from future studies should provide important information that can be used to improve the status of critically ill infants well beyond the neonatal period. Conclusion A better understanding of GI development nutrition and metabolism and application of this understanding to clinical practice are likely to have a major impact on not only short-term morbidity, but also on the quality of survival into adulthood and succeeding generations. This constitutes one of our most current challenging areas in neonatology. Suggested Reading Antonowicz I, Lebenthal E. Developmental pattern of small intestinal enterokinase and disaccharidase activities in the human fetus. Gastroenterology. 1977;72:1299 –1303 Armand M, Hamosh M, Mehta NR, et al. Effect of human milk or formula on gastric function and fat digestion in the premature infant. Pediatr Res. 1996;40:429 – 437 Berseth CL. Gastrointestinal motility in the neonate. Clin Perinatol. 1996;23:179 –190 Brans YW, Ritter DA, Kenny JD, Andrew DS, Dutton EB, Carrillo DW. Influence of intravenous fat emulsion on serum bilirubin in very low birthweight neontates. Arch Dis Child. 1987;62: 156 –160 Foote KD, MacKinnon MJ, Innis SM. Effect of early introduction of formula vs fat-free parenteral nutrition on essential fatty acid status of preterm infants. Am J Clin Nutr. 1991;54:93–97 Hamosh M. Digestion in the newborn. Clin Perinatol. 1996;23: 191–209 Hyman PE, Abrams C, Dubors A. Effect of metaclopramide and bethanacol on gastric emptying in infants. Pediatr Res. 1985; 19:1029 Hyman PE, Clarke DD, Everett SL, et al. Gastric acid secretory function in preterm infants. J Pediatr. 1985;106:467– 471 Janssens G, Melis K, Vaerenberg M. Long-term use of cisapride (Propulsid) in premature neonates of ⬍34 weeks gestational age. J Pediatr Gastroentrol Nutr. 1990;11:420 Kelly EJ, Newell SJ, Brownlee KG, Promrose JN, Dear PR. Gastric acid secretion in preterm infants. Early Human Dev. 1993;35: 215–220 Kien CL. Digestion, absorption, and fermentation of carbohydrates in the newborn. Clin Perinatol. 1996;23:211–228 Koldovsky O. Small and large intestine. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. Vol 2. Philadelphia, Pa: WB Saunders; 1992:1059 NeoReviews Vol.4 No.1 January 2003 e11 Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 gastroenterology anatomy & physiology Kunz C, Rudloff S. Biological functions of oligosaccharides in human milk. Acta Pediatr. 1993;82:903–912 La Gamma EF, Browne LE. Feeding practices for infants weighing less than 1500 grams at birth and the pathogenesis of necrotizing enterocolitis. Clin Pernatol. 2000;21:271–306 Leung AK, Liay PC. Use of metoclopramide in the treatment of gastroesophageal reflux in infants and children. Curr Ther Res. 1984;36:911 Murray RD, Kerzner B, Sloan HR, McClung HJ, Gilbert M, Ailabouni A. The contribution of salivary amylase to glucose polymer hydrolysis in premature infants. Pediatr Res. 1986;20: 186 –191 Neu J. Feeding strategies of the premature/sick infant. In: Lifshitz C, ed. Pediatric Gastroenterology and Nutrition in Clinical Practice. New York, NY: Marcel Dekker, Inc; 2002:203–222 Newell SJ, Sarkar PK, Durbin G. Maturation of the lower oesophageal sphincter function in the preterm baby. Gut. 1988;29: 1677 e12 NeoReviews Vol.4 No.1 January 2003 Novak DA. Gastroesophageal reflux in the preterm infant. Clin Perinatol. 1996;23:305–320 Rubin M, Naor N, Sirota L, et al. Are bilirubin and plasma lipid profiles of premature infants dependent on the lipid emulsion infused? J Pediatr Gastroenterol Nutr. 1995;21:25–30 Siegel M. Gastric emptying time in premature and compromised infants. J Pediatr Gastroenterol Nutr. 1983;2(suppl 1):S136 Thureen PJ, Hay WW Jr. Early aggressive nutrition in preterm infants. Semin Perinatol. 2001;6:403– 415 Widdowson EM. Changes in body proportions and composition during growth. In: Davis JA, Dobbing J, eds. Scientific Foundations of Pediatrics. Philadelphia, Pa: WB Saunders; 1974: 153–163 Young VR. 2001 W. O. Atwater Memorial Lecture and the 2001 ASNS President’s Lecture: human nutrient requirements: the challenge of the post-genome era. J Nutr. 2002;132:621– 629 Ziegler EE. Protein in premature feeding. Nutrition. 1994;10: 69 –71 Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 gastroenterology anatomy & physiology NeoReviews Quiz 1. An infant is delivered at 26 weeks’ gestation following spontaneous preterm labor and rapid progression. An understanding of the anatomic and physiologic development of the gastrointestinal tract would be helpful in determining the nutrition management of this infant. Of the following, the most accurate statement regarding the gastrointestinal structure and function of this infant is that: A. B. C. D. E. Crypt-to-villus epithelial migration time is 48 hours. Gastroanal transit time is 8 hours. Intestinal length is 275 cm. Intragastric pH is 6.0. Lower esophageal sphincter pressure is 28 cm H2O. 2. Numerous types of cells that have differing functions are present in the small intestine. Of the following, the cell most involved in the secretion of defensins as a part of innate immunity is the: A. B. C. D. E. Dendritic cell. Enteroendocrine cell. Goblet cell. M cell. Paneth cell. 3. The digestion and absorption of protein, lipid, and carbohydrate varies in infants, depending on the maturation of the fetus as gestation advances. Of the following, the most accurate statement regarding digestive/absorptive function in the neonate is that: A. Decreased bile acid synthesis in the preterm neonate causes inefficient absorption of medium-chain triglycerides. B. Enterokinase enzyme activity is detectable at 24 weeks of gestational age. C. Gastric acid secretion is responsive to pentagastrin in the first 48 hours after birth. D. Pancreatic amylase activity reaches its mature level at birth in a term neonate. E. Pepsin enzyme activity is fully developed at birth in a term neonate. 4. Minimal enteral nutrition is a feeding strategy for preterm neonates that is intended to enhance maturation of the gastrointestinal motor patterns with release of related hormones. Of the following, the gastrointestinal motor responses are most likely to be increased by: A. B. C. D. E. Dilution of milk. Route of feeding. Slow rate of infusion. Temperature of feedings. Volume of milk. NeoReviews Vol.4 No.1 January 2003 e13 Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008 The Neonatal Gastrointestinal Tract: Developmental Anatomy, Physiology, and Clinical Implications Josef Neu and Nan Li NeoReviews 2003;4;7 DOI: 10.1542/neo.4-1-e7 Updated Information & Services including high-resolution figures, can be found at: http://neoreviews.aappublications.org/cgi/content/full/neoreview s;4/1/e7 Supplementary Material Supplementary material can be found at: http://neoreviews.aappublications.org/cgi/content/full/neoreview s;4/1/e7/DC1 Permissions & Licensing Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at: http://neoreviews.aappublications.org/misc/Permissions.shtml Reprints Information about ordering reprints can be found online: http://neoreviews.aappublications.org/misc/reprints.shtml Downloaded from http://neoreviews.aappublications.org by JoDee Anderson on June 20, 2008